Warning: fopen(includes/rss-cache/amazon-Books-Cancer) [function.fopen]: failed to open stream: No such file or directory in /home/jen1527/public_html/stage4cancersite.com/includes/amazon.php on line 984
Warning: fwrite(): supplied argument is not a valid stream resource in /home/jen1527/public_html/stage4cancersite.com/includes/amazon.php on line 985
Warning: fclose(): supplied argument is not a valid stream resource in /home/jen1527/public_html/stage4cancersite.com/includes/amazon.php on line 986
Cancer dad tells men not to ignore warning signs - Glasgow Evening Times
Cancer dad tells men not to ignore warning signs Glasgow Evening Times A GRANDAD is warning others to learn the signs of the most common cancer in men after revealing he waited seven years to get a test that could have saved his life. Gerry Hagan was diagnosed with advanced prostate cancer, which had spread to his bones ...
Awareness key to treatment, say experts The News International World Cancer Day (WCD) was observed by various public and private health institutions and organisations of Karachi on Saturday. They organised awareness activities, seminars and conferences to highlight the early warning signs, symptoms and diagnosis ...
Study questions proton therapy for prostate cancer - Fox News
Study questions proton therapy for prostate cancer Fox News Print Email Share Comments Recommend Tweet A warning to men considering a pricey new treatment for prostate cancer called proton therapy: Research suggests it might have more side effects than traditional radiation does. A study of Medicare records ...
Cancer - Know Your Chances AllAfrica.com While skin cancer is common in both men and women, prostate-, lung- and oesophagus cancer affect many men South Africa, while breast-, cervical- and endometrial cancer is most common in women. It is important to note that having the symptoms explained ...
Is AstraZeneca a sign of wider pharmaceutical woes? - BBC News
Is AstraZeneca a sign of wider pharmaceutical woes? BBC News In February 2011, late-stage clinical trials were halted on the prostate cancer drug zibotentan. Mr De Pass says part of the reason is the move to more challenging targets such as cancer and the brain. "[Treating] Alzheimer's is a bit like landing ...